Phase to Phase: The Guide to Drug Development
Sponsored by Thermo Fisher Scientific and PPD, experts will present innovative strategies in outsourcing discovery that allows small companies to focus on their core discovery needs and frees them up from both a capital and manpower investment. In this session, hear from experts on rare disease clinical development.
Topics:
- Regulatory benefits when developing a rare disease drug or device.
- The importance of natural history data in rare indications.
- Patient-centricity and other operational aspects of rare disease clinical trials.
